.svg){kind=small}
Hosted in Boston in collaboration with the British Consulate, this event highlights groundbreaking strategies and partnerships accelerating healthcare advancements. Our team will discuss initiatives focusing on innovative treatment pathways and technological breakthroughs. From AI-driven diagnostics to next-generation therapies, the topics are designed to inspire transformative collaborations. Reach out to schedule a discussion with us and explore how our expertise aligns with your goals in innovation.
Find out more about the event here: N/A
-min.jpg)
.jpg)
Latest news
Richmond Appoints Lisa Campbell as Director of Regulatory Strategy
April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read moreVon Willebrand Disease – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol
April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read moreEvents
Swiss Biotech Day 2025
5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event
